MedTrace Logo

The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo

NCT03116672 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-04-18

No results posted yet for this study

Summary

Aim. To compare the outcome of preoperative administration of single-dose ketorolac, non-steroidal anti-inflammatory drug and placebo on postoperative pain in teeth with irreversible pulpitis and apical periodontitis.

Conditions

  • Pulpitis - Irreversible

Interventions

DRUG

one dose ketorolac 10 mg

Administration of ketorolac 10mg, (Dolac) 15 minutes before the clinical procedure.

DRUG

One dose Diclofenac

Administration of diclofenac, (Diclofenaco) 15 minutes before the clinical procedure.

DRUG

Placebo oral capsule

Administration of Placebo, 15 minutes before the clinical procedure.

Sponsors & Collaborators

  • Universidad Autonoma de Baja California

    lead OTHER

Principal Investigators

  • Miguel O Osuna, DDS · SECRETARIA DE SALUD DE BC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-02
Primary Completion
2017-02-06
Completion
2017-02-10

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03116672 on ClinicalTrials.gov